Skip to content
Secondary Progressive MS treatment fast-tracked for FDA Approval
avatar
hackwriter posted:
Opexa has changed the name of its drug, Tovaxin, to Tcelna, as it relaunches Phase IIb trials in 2012 in SPMS patients. See details in the link below:

http://www.opexatherapeutics.com/?page=tovaxin&section=tovaxin

Currently there is only one FDA-approved treatment for SPMS. Novantrone, originally a cancer chemotherapy, is an infusion therapy performed once every three months for up to 24 months for the treatment of Secondary-Progressive MS.
Was this Helpful?
2 of 3 found this helpful
Reply


Helpful Tips

Help Our Community & Experts Help You - Please Read
Welcome to the WebMD Multiple Sclerosis Community! Please don't respond to this discussion. Instead, please read before you start your ... More
Was this Helpful?
106 of 108 found this helpful

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.